Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer

NCT00558103 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

163

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Breast

Interventions

DRUG: lapatinib
DRUG: Pazopanib

Sponsor

GlaxoSmithKline